Integrated genomics of ovarian xenograft tumor progression and chemotherapy response.

Stuckey, Ashley; Fischer, Andrew; Miller, Daniel H; Hillenmeyer, Sara; Kim, Kyu K; Ritz, Anna; Singh, Rakesh K; Raphael, Benjamin J; Brard, Laurent; Brodsky, Alexander S

Stuckey, Ashley; Fischer, Andrew; Miller, Daniel H; Hillenmeyer, Sara; Kim, Kyu K; Ritz, Anna; Singh, Rakesh K; Raphael, Benjamin J; Brard, Laurent; Brodsky, Alexander S.

Affiliation

Stuckey A; Molecular Therapeutics Laboratory, Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants7 Hospital, Alpert Medical School of Brown University, Providence, RI 02905, USA.

BMC Cancer ; 11: 308, 2011 Jul 22.

Article in En | MEDLINE | ID: mdl-21781307

Subject(s)

Antineoplastic Agents/pharmacology; Gene Expression Profiling/methods; Genomics/methods; Ovarian Neoplasms/drug therapy; Ovarian Neoplasms/genetics; Xenograft Model Antitumor Assays; Animals; Apoptosis/drug effects; Cell Line, Tumor; Cell Survival/drug effects; Cisplatin/pharmacology; Cluster Analysis; Ergocalciferols/chemistry; Ergocalciferols/pharmacology; Female; Gene Expression Regulation, Neoplastic/drug effects; Humans; Mice; Mice, Nude; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms/pathology; PPAR gamma/agonists; PPAR gamma/genetics; PPAR gamma/metabolism; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones/pharmacology; Transcriptome; Tumor Burden/drug effects; Vitamins/chemistry; Vitamins/pharmacology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Gene Expression Profiling / Xenograft Model Antitumor Assays / Genomics / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2011 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google